|
1
|
Muslumanoglu AY, Binbay M, Yuruk E, et al:
Updated epidemiologic study of urolithiasis in Turkey. I: changing
characteristics of urolithiasis. Urol Res. 39:309–314. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ertan P, Tekin G, Oger N, Alkan S and
Horasan GD: Metabolic and demographic characteristics of children
with urolithiasis in Western Turkey. Urol Res. 39:105–110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koyuncu HH, Yencilek F, Eryildirim B and
Sarica K: Family history in stone disease: how important is it for
the onset of the disease and the incidence of recurrence? Urol Res.
38:105–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khan SR and Canales BK: Genetic basis of
renal cellular dysfunction and the formation of kidney stones. Urol
Res. 37:169–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fjellstedt E, Harnevik L, Jeppsson JO,
Tiselius HG, Soderkvist P and Denneberg T: Urinary excretion of
total cystine and the dibasic amino acids arginine, lysine and
ornithine in relation to genetic findings in patients with
cystinuria treated with sulfhydryl compounds. Urol Res. 31:417–425.
2003. View Article : Google Scholar
|
|
6
|
Atanassova SS, Panchev P and Ivanova M:
Plasma levels and urinary excretion of amino acids by subjects with
renal calculi. Amino Acids. 38:1277–1282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kepka-Lenhart D, Ash DE and Morris SM:
Determination of mammalian arginase activity. Methods Enzymol.
440:221–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kohri K, Takada M, Katoh Y, Kataoka K,
Iguchi M and Kurita T: Amino acids in urine and plasma of
urolithiasis patients. Int Urol Nephrol. 21:9–16. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Azoury R, Garti N and Sarig S: The amino
acid factor in stone formers’ and normal urines. Urol Res.
14:295–298. 1986.
|
|
10
|
Casero RA and Pegg AE: Polyamine
catabolism and disease. Biochem J. 421:323–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matthews HR: Polyamines, chromatin
structure and transcription. Bioessays. 15:561–566. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aziz SM, Toborek M, Hennig B, Endean E and
Lipke DW: Polyamine regulatory processes and oxidative stress in
monocrotaline-treated pulmonary artery endothelial cells. Cell Biol
Int. 21:801–812. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Igarashi K, Ueda S, Yoshida K and
Kashiwagi K: Polyamines in renal failure. Amino Acids. 31:477–483.
2006. View Article : Google Scholar
|
|
14
|
Sakata K, Kashiwagi K, Sharmin S, et al:
Increase in putrescine, amine oxidase, and acrolein in plasma of
renal failure patients. Biochem Biophys Res Commun. 305:143–149.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakata K, Kashiwagi K, Sharmin S, Ueda S
and Igarashi K: Acrolein produced from polyamines as one of the
uraemic toxins. Biochem Soc Trans. 31:371–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Igarashi K and Kashiwagi K: Use of
polyamine metabolites as markers for stroke and renal failure.
Methods Mol Biol. 720:395–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bello-Fernandez C, Packham G and Cleveland
JL: The ornithine decarboxylase gene is a transcriptional target of
c-Myc. Proc Natl Acad Sci USA. 90:7804–7808. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo Y, Harris RB, Rosson D, Boorman D and
O’Brien TG: Functional analysis of human ornithine decarboxylase
alleles. Cancer Res. 60:6314–6317. 2000.PubMed/NCBI
|
|
19
|
Kondo T, Hamajima N, Nishio K, et al:
Association of a polymorphism in the ornithine decarboxylase gene
with whole blood polyamine concentrations in a non-smoking healthy
population. J Health Sci. 53:406–412. 2007. View Article : Google Scholar
|
|
20
|
Seiler N, Atanassov CL and Raul F:
Polyamine metabolism as target for cancer chemoprevention (Review).
Int J Oncol. 13:993–1006. 1998.PubMed/NCBI
|
|
21
|
Xiao L, Celano P, Mank AR, et al:
Structure of the human spermidine/spermine N1-acetyltransferase
gene (exon/intron gene organization and localization to Xp22.1).
Biochem Biophys Res Commun. 187:1493–1502. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tomitori H, Nenoi M, Mita K, Daino K,
Igarashi K and Ichimura S: Functional characterization of the human
spermidine/spermine N(1)-acetyltransferase gene promoter. Biochim
Biophys Acta. 1579:180–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sequeira A, Gwadry FG, Ffrench-Mullen JM,
et al: Implication of SSAT by gene expression and genetic variation
in suicide and major depression. Arch Gen Psychiatry. 63:35–48.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boyce WH and Sulkin NM: Biocolloids of
urine in health and in calculous disease. III. The mucoprotein
matrix of urinary calculi. J Clin Invest. 35:1067–1079. 1956.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Canales BK, Anderson L, Higgins L, et al:
Proteomic analysis of a matrix stone: a case report. Urol Res.
37:323–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coe FL, Evan AP, Worcester EM and Lingeman
JE: Three pathways for human kidney stone formation. Urol Res.
38:147–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahmed K, Dasgupta P and Khan MS: Cystine
calculi: challenging group of stones. Postgrad Med J. 82:799–801.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brown I, Halliday S, Greig H, Heys SD,
Wallace HM and Schofield AC: Genetic polymorphism in ornithine
decarboxylase and risk of breast cancer. Fam Cancer. 8:307–311.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zell JA, Ziogas A, Ignatenko N, et al:
Associations of a polymorphism in the ornithine decarboxylase gene
with colorectal cancer survival. Clin Cancer Res. 15:6208–6216.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barry EL, Baron JA, Bhat S, et al:
Ornithine decarboxylase polymorphism modification of response to
aspirin treatment for colorectal adenoma prevention. J Natl Cancer
Inst. 98:1494–1500. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zell JA, McLaren CE, Chen WP, Thompson PA,
Gerner EW and Meyskens FL: Ornithine decarboxylase-1 polymorphism,
chemoprevention with eflornithine and sulindac, and outcomes among
colorectal adenoma patients. J Natl Cancer Inst. 102:1513–1516.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Das D, De Fonseka N and Das I:
Interactions of nitric oxide, free radicals and polyamines in the
membrane pathology of schizophrenia. Biochem Soc Trans.
26:S1431998.PubMed/NCBI
|
|
34
|
Bermudo-Soriano CR, Vaquero-Lorenzo C,
Diaz-Hernandez M, et al: SAT-1 −1415T/C polymorphism and
susceptibility to schizophrenia. Prog Neuropsychopharmacol Biol
Psychiatry. 33:345–348. 2009.
|
|
35
|
Vaquero-Lorenzo C, Riaza Bermudo-Soriano
C, Perez-Rodriguez MM, et al: Positive association between SAT-1
−1415T/C polymorphism and anxiety. Am J Med Genet B Neuropsychiatr
Genet. 150B:515–519. 2009.PubMed/NCBI
|
|
36
|
Guipponi M, Deutsch S, Kohler K, et al:
Genetic and epigenetic analysis of SSAT gene dysregulation in
suicidal behavior. Am J Med Genet B Neuropsychiatr Genet.
150B:799–807. 2009. View Article : Google Scholar : PubMed/NCBI
|
